The safety results of ACASA-TAVI and NOTION-4 were discordant as well, Windecker said. “But please note that overall event numbers were very low, the treatment estimates are imprecise, and the ...

The lack of impact on outcomes was surprising, says the investigator, though the FAST-CTCA trial may still come through.

An intervention in rural China continued to impact hypertension, CV events, and dementia risk 4 years after it ended.

While there was no change in disability-free survival, the results should impact guidelines, says François Mach.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

As the first TTVR trial to impact HF hospitalization and mortality, it “feels like a COAPT-like moment,” says Mohamad ...

SWITCH-SWEDEHEART’s unique design randomized healthcare regions but wasn’t a head-to-head comparison with ticagrelor.

The study supports a strategy of going wire-free for functional assessment in this setting and may well be “practice changing ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

The CMR GUIDE trial didn’t meet its primary endpoint but did point to possible positives, especially in younger patients.

Among patients with nonobstructive hypertrophic cardiomyopathy (HCM), the selective cardiac myosin inhibitor aficamten ...